Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
1
x
$
30.00
Gregory J. Moore, PhD: Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders
1
x
$
30.00
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
1
x
$
30.00
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
1
x
$
30.00
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
1
x
$
30.00
VOL 2 No. 3 Full Issue - March 2000
1
x
$
20.00
THE CONTEMPORARY MANAGEMENT OF LUNG CANCER
1
x
$
30.00
View Cart
Checkout
Home
but-is-it-sufficient
Sort by
Popularity
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
R. Bart Sangal, MD: What Is a Significant Response in Drug Studies of Attention- Deficit/Hyperactivity Disorder: Statistical Significance Is Necessary, But Is It Sufficient?
$
30.00
Add to cart
Details
Page load link
Go to Top
